Literature DB >> 22584924

Efficacy of TVT-SECUR and factors affecting cure of female stress urinary incontinence: 3-year follow-up.

Ji-Yeon Han1, Junsoo Park, Myung-Soo Choo.   

Abstract

INTRODUCTION AND HYPOTHESIS: The aim of this study was to evaluate the efficacy of the TVT-SECUR procedure for treating stress urinary incontinence (SUI) and to identify factors affecting cure during 3 years of follow-up.
METHODS: We prospectively followed patients until 1 year postoperatively and contacted them to revisit the clinic at 3 years. Ninety-six women who underwent TVT-SECUR (H type: 42, U type: 54) were followed up for at least 3 years. Patients were evaluated using the Severity Index for Urinary Incontinence, the Incontinence Quality of Life questionnaire, and the Bristol Female Lower Urinary Tract Symptom-Short Form questionnaire at baseline and at each postoperative visit. Patient satisfaction and complications were evaluated. Surgical outcome was assessed according to the Severity Index for Urinary Incontinence. Multivariate regression analysis was used to identify preoperative factors independently associated with cure.
RESULTS: The 3-year success rate was 91.7 % (cure 72.9 %, improved 18.8 %). The success rate was maintained from 94.8 % at 1 year to 91.7 % at 3 years, but the cure rate decreased significantly from 85.4 % at 1 year to 72.9 % at 3 years. Patient satisfaction rate was 85.4 %. Cure rates were lower in patients with Valsalva leak point pressure (VLPP) <60 cmH(2)O (79.5 % vs. 52.2 %, p = 0.010). Multivariate analysis showed that only low VLPP was associated with a lower cure rate.
CONCLUSIONS: The cure rate of female SUI after the TVT-SECUR procedure was not sustained, but the overall success rate was maintained over time. Low VLPP predicted failure to sustain cure.

Entities:  

Mesh:

Year:  2012        PMID: 22584924     DOI: 10.1007/s00192-012-1809-9

Source DB:  PubMed          Journal:  Int Urogynecol J        ISSN: 0937-3462            Impact factor:   2.894


  30 in total

1.  Transobturator TVT-O versus retropubic TVT: results of a multicenter randomized controlled trial at 24 months follow-up.

Authors:  Xavier Deffieux; Nagib Daher; Aslam Mansoor; Philippe Debodinance; Joël Muhlstein; Hervé Fernandez
Journal:  Int Urogynecol J       Date:  2010-06-16       Impact factor: 2.894

2.  Presentation and management of major complications of midurethral slings: Are complications under-reported?

Authors:  Donna Y Deng; Matthew Rutman; Shlomo Raz; Larissa V Rodriguez
Journal:  Neurourol Urodyn       Date:  2007       Impact factor: 2.696

3.  Stress Urinary Incontinence.

Authors:  E J McGuire; B Lytton; V Pepe; E I Kohorn
Journal:  Obstet Gynecol       Date:  1976-03       Impact factor: 7.661

4.  A randomized trial comparing tension-free vaginal tape with tension-free vaginal tape-obturator: 36-month results.

Authors:  Kirsi Palva; Kirsi Rinne; Pauliina Aukee; Aarre Kivelä; Eija Laurikainen; Teuvo Takala; Antti Valpas; Carl Gustaf Nilsson
Journal:  Int Urogynecol J       Date:  2010-05-04       Impact factor: 2.894

5.  Midterm prospective evaluation of TVT-Secur reveals high failure rate.

Authors:  Jean-Nicolas Cornu; Philippe Sèbe; Laurence Peyrat; Calin Ciofu; Olivier Cussenot; Francois Haab
Journal:  Eur Urol       Date:  2010-04-23       Impact factor: 20.096

6.  Tension-Free vaginal tape (TVT) in women with mixed urinary incontinence--a long-term follow-up.

Authors:  M Rezapour; U Ulmsten
Journal:  Int Urogynecol J Pelvic Floor Dysfunct       Date:  2001

7.  Single-incision sling system as primary treatment of female stress urinary incontinence: prospective 12 months data from a single institution.

Authors:  Rui Oliveira; Francisco Botelho; Pedro Silva; Alexandre Resende; Carlos Silva; Paulo Dinis; Francisco Cruz
Journal:  BJU Int       Date:  2011-04-01       Impact factor: 5.588

8.  The Bristol Female Lower Urinary Tract Symptoms questionnaire: development and psychometric testing.

Authors:  S Jackson; J Donovan; S Brookes; S Eckford; L Swithinbank; P Abrams
Journal:  Br J Urol       Date:  1996-06

9.  Novel surgical technique for the treatment of female stress urinary incontinence: transobturator vaginal tape inside-out.

Authors:  Jean de Leval
Journal:  Eur Urol       Date:  2003-12       Impact factor: 20.096

10.  Evaluation and outcome measures in the treatment of female urinary stress incontinence: International Urogynecological Association (IUGA) guidelines for research and clinical practice.

Authors:  G Ghoniem; E Stanford; K Kenton; C Achtari; R Goldberg; T Mascarenhas; M Parekh; K Tamussino; S Tosson; G Lose; E Petri
Journal:  Int Urogynecol J Pelvic Floor Dysfunct       Date:  2007-11-17
View more
  6 in total

Review 1.  Advances in the SUI Surgeries.

Authors:  Arun Nayak
Journal:  J Obstet Gynaecol India       Date:  2017-03-17

2.  Mini-slings can cause complications.

Authors:  Burhan Coskun; Rebecca S Lavelle; Feras Alhalabi; Gary E Lemack; Philippe E Zimmern
Journal:  Int Urogynecol J       Date:  2014-10-23       Impact factor: 2.894

3.  To evaluate the safety and efficacy of the TVT-Secur procedure in the treatment of stress urinary incontinence in women.

Authors:  J S Sandhu; S C Karan; G D Maiti; Puja Dudeja
Journal:  Med J Armed Forces India       Date:  2016-09-05

4.  Three-year results from a randomised trial of a retropubic mid-urethral sling versus the Miniarc single incision sling for stress urinary incontinence.

Authors:  Maya Basu; Jonathan Duckett
Journal:  Int Urogynecol J       Date:  2013-05-28       Impact factor: 2.894

5.  Randomized controlled trial comparing TVT-O and TVT-S for the treatment of stress urinary incontinence: 2-year results.

Authors:  Ana Maria H M Bianchi-Ferraro; Zsuzsanna I K Jarmy-DiBella; Rodrigo de Aquino Castro; Maria Augusta T Bortolini; Marair G F Sartori; Manoel J B C Girão
Journal:  Int Urogynecol J       Date:  2014-03-19       Impact factor: 2.894

6.  Efficacy and Safety of Tension-Free Vaginal Tape-Secur Mini-Sling Versus Standard Midurethral Slings for Female Stress Urinary Incontinence: A Systematic Review and Meta-Analysis.

Authors:  Wei Huang; Tao Wang; Huantao Zong; Yong Zhang
Journal:  Int Neurourol J       Date:  2015-12-28       Impact factor: 2.835

  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.